Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-β-induced nuclear accumulation

American Journal of Physiology - Cell Physiology

Volumn 285, Issue 4 54-4, 2003, Pages

  Roelen, Bernard A J ^a   Cohen, Ori S ^a   Raychowdhury, Malay K ^a   Chadee, Deborah N ^b   Zhang, Ying ^a   Kyriakis, John M ^b   Alessandrini, Alessandro A ^a   Lin, Herbert Y ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Extracellular signal regulated kinase phosphorylation site; Luciferase reporter; Mitogen activated protein kinase; Phosphopeptide mapping; Signal transduction

Indexed keywords

LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; SMAD4 PROTEIN; THREONINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; LIGAND BINDING; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0141679506     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00053.2003     Document Type: Article

References (27)

1. Barron M, Gao M, and Lough J. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev Dyn 218: 383-393, 2000.
2. Boyle WJ, van der Geer P, and Hunter T. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol 201: 110-149, 1991.
3. De Caestecker MP, Hemmati P, Larisch-Bloch S, Ajmera R, Roberts AB, and Lechleider RJ. Characterization of functional domains within Smad4/DPC4. J Biol Chem 272: 13690-13696, 1997.
4. De Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, Roberts AB, and Lechleider RJ. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 12: 1587-1592, 1998.
5. De Caestecker MP, Yahata T, Wang D, Parks WT, Huang S, Hill SH, Shioda T, Roberts AB, and Lechleider RJ. The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem 275: 2115-2122, 2000.
6. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, and Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100, 1998.
7. Engel ME, McDonnel MA, Law BK, and Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. JBiol Chem 274: 37413-37420, 1999.
8. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitt WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, and Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632, 1998.
9. Frenz DA, Liu W, Williams JD, Hatcher V, Galinovic-Schwartz V, Flanders KC, and Van De Water TR. Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development 120: 415-424, 1994.
10. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, and Kern SE. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353, 1996.
11. Hata A, Lo RS, Wotton D, Lagna G, and Massagué J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388: 82-87, 1997.
12. Heldin CH, Miyazono K, and ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997.
13. Kretzschmar M, Doody J, and Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smadl. Nature 389: 618-622, 1997.
14. Kretzschmar M, Doody J, Timokhina I, and Massagué J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev 13: 804-816, 1999.
15. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, and Wrana JL. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215-1224, 1996.
16. Mulder KM. Role of Ras and Mapks in TGFβ signaling. Cytokine Growth Factor Rev 11: 23-35, 2000.
17. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, and ten Dijke P. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16: 5353-5362, 1997.
18. Pierreux CE, Nicolás FJ, and Hill CS. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol 20: 9041-9054, 2000.
19. Plisov SY, Yoshino K, Dove LF, Higinbotham KG, Rubin JS, and Perantoni AO. TGF-β2, LIF and FGF2 cooperate to induce nephrogenesis. Development 128: 1045-1057, 2001.
20. Qin B, Lam SS, and Lin K. Crystal structure of a transcriptionally active Smad4 fragment. Structure Fold Des 7: 1493-1503, 1999.
21. Saha D, Datta PK, and Beauchamp RD. Oncogenic ras represses transforming growth factor-beta/Smad signaling by degrading tumor suppressor Smad4. J Biol Chem 276: 29531-29537, 2001.
22. Schutte M, Hruban RH, Hedrick L, Cho KR, Molnar Nadasdy G, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA, Meltzer PS, Hahn SA, and Kern SA. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 56: 2527-2530, 1996.
23. Shi Y, Jayaraman L, Yang H, Massagué J, and Pavletich NP. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell 94: 585-594, 1998.
24. Stern HM, Lin-Jones J, and Hauschka SD. Synergistic interactions between bFGF and a TGF-β family member may mediate myogenic signals from the neural tube. Development 124:3511-3523, 1997.
25. De Winter JP, Roelen BAJ, ten Dijke P, van der Burg B, and van den Eijnden-van Raaij AJM. DPC4 (SMAD4) mediates transforming growth factor-betal (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 14: 1891-1899, 1997.
26. Zawel L, Le Dai J, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, and Kern SE. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1: 611-617, 1998.
27. Zhang Y, Musci T, and Derynck R. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr Biol 7: 270-276, 1997.